Skip to content

Clinical trials

Completed Phase 3 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 3 Status: Completed Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20043
20056
20065
20074
20083
20092
20113
20126
20131
20145
20153
20162
20173
20195
20203
20214
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen9
Shandong University5
GlaxoSmithKline4
Rigel Pharmaceuticals3
argenx3
AO GENERIUM2
Jiangsu HengRui Medicine Co., Ltd.2
Novartis Pharmaceuticals2
Octapharma2
Ostfold Hospital Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic65
Thrombocytopenia18
Purpura7
Purpura, Thrombocytopenic6
Hemorrhage4
Hemostatic Disorders3
Ecchymosis2
Hematologic Diseases2
Blood Platelet Disorders1
Immune System Diseases1

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.